First Mercantile Trust’s Standard BioTools LAB Stock Holding History

First Mercantile Trust’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-9,700	Closed	-$238K	–	1119
2014 Q3	$238K	Sell	9,700 -3,526	-27%	-$99.1K	0.02%	687
2014 Q2	$389K	Sell	13,226 -6,565	-33%	-$210K	0.03%	573
2014 Q1	$872K	Buy	19,791 +7,090	+56%	+$312K	0.06%	424
2013 Q4	$487K	Buy	12,701 +4,604	+57%	+$136K	0.04%	570
2013 Q3	$178K	Buy	+8,097	New	+$159K	0.01%	761

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Mercantile Trust's LAB Position: Q4 2014 in Review

First Mercantile Trust sold out of Standard BioTools (LAB) in Q4 2014, closing a stake of 9,700 shares — an estimated $238K sold.

First Mercantile Trust first reported a position in LAB in Q3 2013 and held it in 5 quarters. The position peaked at $872K in Q1 2014. 100 funds tracked by Wall St. Rank hold LAB as of Q4 2014.

First Mercantile Trust reported no remaining Standard BioTools position as of Q4 2014 after selling out during the quarter.
First Mercantile Trust sold 9,700 Standard BioTools shares in Q4 2014, an estimated $238K.
First Mercantile Trust first reported a position in Standard BioTools in Q3 2013 and held it in 5 quarters.
First Mercantile Trust's Standard BioTools position peaked at $872K in Q1 2014.
100 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2014.

Based on First Mercantile Trust's 13F filing for Q4 2014, filed 7 Jan 2015.